FDA Inspection 698518 — Medicap Laboratories
The FDA completed an inspection of Medicap Laboratories on November 18, 2010 in Etobicoke. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- November 18, 2010
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Etobicoke (Canada)